trial
as of 2026-07-01Pyridoxal Kinase Activity in Tardive Dyskinesia
NCTId NCT01908452
at a glance
Phase 3 · Withdrawn
Enrollment 0 (actual)
Sponsored by Beersheva Mental Health Center
Primary completion 2011-07
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 3
Status
Withdrawn
Enrollment
0 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2011-07
Primary completion
2011-07
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Drugs
Sponsors
Beersheva Mental Health CenterLead Sponsor
Sha'ar Menashe Mental Health CenterCollaborator
Tirat Carmel Mental Health CenterCollaborator
Sites
3 total
Beersheba, IsraelHadera, IsraelHaifa, Israel
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
0
Phase
PHASE3
Primary Completion Date
2011-07
Status
WITHDRAWN
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication